Zevra Therapeutics, Inc. ZVRA Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s income tax?
- Zevra Therapeutics, Inc. (ZVRA) reported income tax of $6.91M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s income tax changed year-over-year?
- Zevra Therapeutics, Inc.'s income tax increased by 484.9% year-over-year, from $1.18M to $6.91M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s income tax?
- Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s income tax has grown at a 366.4% compound annual growth rate (CAGR), from $34K to $3.45M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.